Anavex Life Sciences Corp (AVXL)

[falconer66a]

Doesn’t Anavex Threaten Alzheimer’s Experts’ Careers?

“...hardly anyone cares or takes avxl seriously.”

That’s a thought we need to ponder—that the real reason Anavex technologies are literally unremarkable, without any experts testifying against them, is because the Anavex molecules are so unproven and could not possibly have any important impact on anything or anyone. Not a matter of any useful discussion whatsoever. A mere inconsequential medical curiosity of no eventual consequence.

Now, I’m convinced. The Anavex story really is bogus.

One might think that if Anavex 2-73 appeared to eventually yield a profound treatment and prophylaxis outcome, the billions of dollars of medical careers, Alzheimer’s treatment and care centers, and entire medical school faculty positions might be jeopardized. In those are thousands of professionals whose careers are focused on the continuing and expanding neurological diseases Anavex promises to fix or prevent. If Anavex 2-73 proves to successfully treat Rett Syndrome, Parkinson’s Disease, Alzheimer’s Disease, or Amyotrophic Lateral Sclerosis (among others), a lot of medical and care-giving professionals will have career changes.

But, as so apparent, every one of these people, even better than any of us who post here on Ihub, have scrutinized the Anavex data and know with certainty that it will be a medical treatment no-go. Their careers or professional institutions are in no way threatened by Anavex Life Sciences Corp. The threat is so imaginary as to require absolutely no comment. Life will go on perfectly well, no matter what.

The utter lack of any professionally-expressed concerns about the Anavex stuff rather authoritatively indicates its invalidity, does it not?

I’ll be selling my shares at the open tomorrow.